✦ LIBER ✦

Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery

✍ Scribed by C. R. M. HAY; A. HELLMANN; A. DMOSZYNSKA; T. BAGLIN; D. O’SHAUNESSEY; M. MAKRIS; R. SHAIKH-ZAIDI; C. H. DASH

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Optivate®, a high-pu

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Clinical assessment of Optivate®, a high

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Clinical experience with Optivate®, high

✍ M. MATYSIAK; H. BOBROWSKA; W. BALWIERZ; A. CHYBICKA; J. R. KOWALCZYK; R. SHAIKH- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Immune tolerance therapy utilizing facto

✍ M. A. H. KURTH; D. DIMICHELE; C. SEXAUER; J. M. SANDERS; M. TORRES; S. C. ZAPPA; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Efficacy of factor VIII/von Willebrand f

✍ G. E. RIVARD; L. ALEDORT; THE ALPHANATE SURGICAL INVESTIGATORS 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Efficacy and safety of a high purity, do

✍ J. SHORTT; S. DUNKLEY; K. RICKARD; R. BAKER; A. STREET 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB